Sign up to save your podcasts
Or
Share David Schaffer On Taking An Over $1.2 Billion Company Public And Now Building A Stem Cell Therapy Company
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
David Schaffer On Taking An Over $1.2 Billion Company Public And Now Building A Stem Cell Therapy Company
In the world of scientific innovation and entrepreneurship, few names shine as brightly as David Schaffer's. With a track record of launching and nurturing successful companies in the biomedical field, David's journey is not just a story of academic achievement.
The post David Schaffer On Taking An Over $1.2 Billion Company Public And Now Building A Stem Cell Therapy Company appeared first on Alejandro Cremades.
View all episodes
By Alejandro Cremades
4.7
266266 ratings
In the world of scientific innovation and entrepreneurship, few names shine as brightly as David Schaffer's. With a track record of launching and nurturing successful companies in the biomedical field, David's journey is not just a story of academic achievement.
The post David Schaffer On Taking An Over $1.2 Billion Company Public And Now Building A Stem Cell Therapy Company appeared first on Alejandro Cremades.
More shows like DealMakers
View all
Freakonomics Radio
32,061 Listeners
The a16z Show
1,094 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,362 Listeners
NVIDIA AI Podcast
344 Listeners
The Daily
111,929 Listeners
Masters of Scale
3,994 Listeners
Y Combinator Startup Podcast
227 Listeners
Practical AI
205 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,024 Listeners
Last Week in AI
305 Listeners
ACQ2 by Acquired
299 Listeners
AI + a16z
35 Listeners